KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Authors
Keywords
-
Journal
KIDNEY INTERNATIONAL
Volume 102, Issue 5, Pages S1-S127
Publisher
Elsevier BV
Online
2022-10-19
DOI
10.1016/j.kint.2022.06.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
- (2021) Seshagiri Rao Nandula et al. Cardiovascular Diabetology
- SGLT2 Inhibitors in Diabetic Kidney Disease
- (2021) Sophia Zoungas et al. Clinical Journal of the American Society of Nephrology
- Prevention of heart failure events with sodium–glucose co‐transporter 2 inhibitors across a spectrum of cardio‐renal‐metabolic risk
- (2021) Kirtipal Bhatia et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Kidney Function on Relationships between Lifestyle Behaviors and Mortality or Cardiovascular Outcomes: A Pooled Cohort Analysis
- (2021) Sarah J. Schrauben et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Targeting Sedentary Behavior in CKD
- (2021) Kate Lyden et al. Clinical Journal of the American Society of Nephrology
- Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
- (2021) Glenn M. Chertow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Mikhail N Kosiborod et al. Lancet Diabetes & Endocrinology
- Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
- (2021) Rajiv Agarwal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial
- (2021) Kassia S. Beetham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study
- (2020) Hongjiang Wu et al. DIABETOLOGIA
- Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial
- (2020) Masashi Tanaka et al. INTERNAL MEDICINE
- Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease
- (2020) Leila R. Zelnick et al. DIABETES CARE
- Sodium‐glucose cotransporter‐2 ( SGLT ‐2) inhibitors and major adverse limb events: a trial‐level meta‐analysis including 51,713 individuals
- (2020) Chen‐Yu Huang et al. DIABETES OBESITY & METABOLISM
- Assessing the cost‐effectiveness of SGLT2i in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real‐world evidence
- (2020) Phil McEwan et al. DIABETES OBESITY & METABOLISM
- KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
- (2020) T. Alp Ikizler et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study
- (2020) Takashi Wada et al. Clinical and Experimental Nephrology
- Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
- (2020) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis
- (2020) Jaimon T. Kelly et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes.
- (2020) Kohjiro Ueki et al. KIDNEY INTERNATIONAL
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial
- (2020) Hitoshi Minakuchi et al. Scientific Reports
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- Effects of Canagliflozin in Patients with Baseline eGFR
- (2020) George Bakris et al. Clinical Journal of the American Society of Nephrology
- Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)
- (2020) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial
- (2020) Phil McEwan et al. DIABETES OBESITY & METABOLISM
- Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
- (2020) Megumi Oshima et al. KIDNEY INTERNATIONAL
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
- (2020) Bettina J. Kraus et al. KIDNEY INTERNATIONAL
- The combined diabetes and renal control trial (C-DIRECT) - a feasibility randomised controlled trial to evaluate outcomes in multi-morbid patients with diabetes and on dialysis using a mixed methods approach
- (2019) K. Griva et al. BMC Nephrology
- Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis
- (2019) Jiang Pu et al. BMJ Open
- Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
- (2019) Alex R Chang et al. BMJ-British Medical Journal
- Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
- (2019) Josef Coresh et al. Lancet Diabetes & Endocrinology
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
- (2019) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- Secondhand Smoke and CKD
- (2019) Jong Hyun Jhee et al. Clinical Journal of the American Society of Nephrology
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- (2019) Bruce S. Spinowitz et al. Clinical Journal of the American Society of Nephrology
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
- (2019) Alison B. Evert et al. DIABETES CARE
- Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Ashkan Afshin et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation
- (2019) Basil Alnasrallah et al. BMC Nephrology
- Gait Abnormalities and the Risk of Falls in CKD
- (2019) Jeannie Tran et al. Clinical Journal of the American Society of Nephrology
- Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
- (2019) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
- (2019) Carol Pollock et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors
- (2019) Donna K. Arnett et al. JAMA Cardiology
- Healthy Dietary Patterns and Incidence of CKD
- (2019) Katrina E. Bach et al. Clinical Journal of the American Society of Nephrology
- From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
- (2019) Juliana C.N. Chan et al. DIABETES CARE
- The Microalbuminuria Education Medication and Optimisation ( MEMO ) study: 4 years follow‐up of multifactorial intervention in high‐risk individuals with type 2 diabetes
- (2019) W. Crasto et al. DIABETIC MEDICINE
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
- (2019) M. Angelyn Bethel et al. DIABETES CARE
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Catherine M. Clase et al. KIDNEY INTERNATIONAL
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking
- (2018) Perry Formanek et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Different Doses of Irbesartan Combined With Spironolactone on Urinary Albumin Excretion Rate in Elderly Patients With Early Type 2 Diabetic Nephropathy
- (2018) Yingying Chen et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data
- (2018) L. S. Vest et al. CLINICAL TRANSPLANTATION
- Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries—A Systematic Review
- (2018) Mayowa O. Owolabi et al. DIABETES CARE
- Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis
- (2018) Lee Ling Lim et al. DIABETES CARE
- Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial
- (2018) Linong Ji et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study
- (2018) Paola Fioretto et al. DIABETES OBESITY & METABOLISM
- Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
- (2018) Claire C J Dekkers et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis
- (2018) Samuel Seidu et al. Primary Care Diabetes
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Diabetes structured self-management education programmes: a narrative review and current innovations
- (2018) Sudesna Chatterjee et al. Lancet Diabetes & Endocrinology
- Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population
- (2018) Kristina S. Boye et al. Diabetes Therapy
- Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population
- (2018) Kristina S. Boye et al. Diabetes Therapy
- Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
- (2018) Richard M. Bergenstal et al. DIABETES CARE
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes
- (2018) Hsien-Yen Chang et al. JAMA Internal Medicine
- Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants
- (2018) Regina Guthold et al. Lancet Global Health
- Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- (2018) Johannes F. E. Mann et al. CIRCULATION
- Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
- (2018) Amy K. Mottl et al. Clinical Journal of the American Society of Nephrology
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017)
- (2018) Daniela Malta et al. Journal of Clinical Hypertension
- 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
- (2018) Sandeep R. Das et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reprint of: Promoting Physical Activity and Exercise
- (2018) Gerald F. Fletcher et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
- (2018) Christoph Wanner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages
- (2017) Yuhuan Wang et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
- (2017) Erik Nilsson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
- (2017) Marcus Lind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
- (2017) Roy W. Beck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept
- (2017) Leon Fogelfeld et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure
- (2017) Stephen P. Juraschek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease
- (2017) Joshua J. Neumiller et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Obesity and kidney disease: from population to basic science and the search for new therapeutic targets
- (2017) Adam Whaley-Connell et al. KIDNEY INTERNATIONAL
- Physical inactivity: a risk factor and target for intervention in renal care
- (2017) Dorien M. Zelle et al. Nature Reviews Nephrology
- Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies
- (2017) Jia Xia et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations
- (2017) Brian T. Bateman et al. OBSTETRICS AND GYNECOLOGY
- Community health workers in diabetes care: A systematic review of randomized controlled trials.
- (2017) Lisa J. Trump et al. Families Systems & Health
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
- (2017) Sophia Zoungas et al. Lancet Diabetes & Endocrinology
- Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
- (2017) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
- (2017) Kohjiro Ueki et al. Lancet Diabetes & Endocrinology
- Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
- (2017) Gabriela Vega-Hernandez et al. Diabetes Therapy
- Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
- (2017) George Grunberger et al. Diabetes Therapy
- Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
- (2017) Gabriela Vega-Hernandez et al. Diabetes Therapy
- Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
- (2017) George Grunberger et al. Diabetes Therapy
- Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
- (2017) Christoph Wanner et al. CIRCULATION
- Diuretics for Hypertension: A Review and Update
- (2016) George C. Roush et al. AMERICAN JOURNAL OF HYPERTENSION
- The Associations of Plant Protein Intake With All-Cause Mortality in CKD
- (2016) Xiaorui Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
- (2016) Natalie Staplin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial
- (2016) David J. Leehey et al. AMERICAN JOURNAL OF NEPHROLOGY
- Peer Support Interventions for Adults With Diabetes: A Meta-Analysis of Hemoglobin A1c Outcomes
- (2016) S. J. Patil et al. ANNALS OF FAMILY MEDICINE
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
- (2016) I. H. de Boer et al. Clinical Journal of the American Society of Nephrology
- Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus
- (2016) Masakazu Haneda et al. CLINICAL THERAPEUTICS
- Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
- (2016) Harold Bays et al. CURRENT MEDICAL RESEARCH AND OPINION
- The effect of liraglutide on renal function: A randomized clinical trial
- (2016) Bernt J. von Scholten et al. DIABETES OBESITY & METABOLISM
- Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
- (2016) Karolin Bettge et al. DIABETES OBESITY & METABOLISM
- Economic evaluation of chronic disease self-management for people with diabetes: a systematic review
- (2016) C. Teljeur et al. DIABETIC MEDICINE
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
- (2016) Peter Gæde et al. DIABETOLOGIA
- Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive MedicationNovelty and Significance
- (2016) Giuseppe Mancia et al. HYPERTENSION
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Distinct biomarker roles for HbA 1c and glycated albumin in patients with type 2 diabetes on hemodialysis
- (2016) Akinori Hayashi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Red Meat Intake and Risk of ESRD
- (2016) Quan-Lan Jasmine Lew et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial
- (2016) Fabio Manfredini et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review
- (2016) F. Persson et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
- (2016) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women
- (2016) Ulf Ekelund et al. LANCET
- The next generation of therapeutics for chronic kidney disease
- (2016) Matthew D. Breyer et al. NATURE REVIEWS DRUG DISCOVERY
- The Health Effects of Electronic Cigarettes
- (2016) Chitra Dinakar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physical activity and metabolic health in chronic kidney disease: a cross-sectional study
- (2016) Wilson Bowlby et al. BMC Nephrology
- E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis
- (2016) Sara Kalkhoran et al. Lancet Respiratory Medicine
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- Behavioral Programs for Type 2 Diabetes Mellitus
- (2015) Jennifer Pillay et al. ANNALS OF INTERNAL MEDICINE
- Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
- (2015) Aviroop Biswas et al. ANNALS OF INTERNAL MEDICINE
- Use of Continuous Glucose Monitoring in Patients with Diabetes Mellitus on Peritoneal Dialysis: Correlation with Glycated Hemoglobin and Detection of High Incidence of Unaware Hypoglycemia
- (2015) Ahad Qayyum et al. BLOOD PURIFICATION
- Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes MellitusCLINICAL PERSPECTIVE
- (2015) An Pan et al. CIRCULATION
- Dose–Response Relationship Between Physical Activity and Risk of Heart FailureCLINICAL PERSPECTIVE
- (2015) Ambarish Pandey et al. CIRCULATION
- Light-Intensity Physical Activities and Mortality in the United States General Population and CKD Subpopulation
- (2015) S. Beddhu et al. Clinical Journal of the American Society of Nephrology
- Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
- (2015) Melanie J. Davies et al. DIABETES CARE
- Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blinded, Parallel Group, Randomized Trial
- (2015) Thomas Idorn et al. DIABETES CARE
- A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Dia
- (2015) A. Kashiwagi et al. DIABETES OBESITY & METABOLISM
- Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry
- (2015) A. O. Luk et al. DIABETIC MEDICINE
- Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials
- (2015) S. Seidu et al. DIABETIC MEDICINE
- The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients
- (2015) Mark E. Williams et al. Hemodialysis International
- Head-to-Head Comparisons of Hydrochlorothiazide With Indapamide and Chlorthalidone: Antihypertensive and Metabolic Effects
- (2015) G. C. Roush et al. HYPERTENSION
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis
- (2015) Kei Fukami et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease
- (2015) Koshi Nakamura et al. KIDNEY INTERNATIONAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
- (2015) Greg Fulcher et al. Diabetes Therapy
- Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
- (2015) Greg Fulcher et al. Diabetes Therapy
- Metformin Use in Kidney Transplant Recipients in the United States: An Observational Study
- (2015) Jenise Stephen et al. AMERICAN JOURNAL OF NEPHROLOGY
- Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus
- (2014) Koji Harada et al. CLINICAL NEPHROLOGY
- Severe Hypoglycemia Identifies Vulnerable Patients With Type 2 Diabetes at Risk for Premature Death and All-Site Cancer: The Hong Kong Diabetes Registry
- (2014) Alice P.S. Kong et al. DIABETES CARE
- Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
- (2014) Bruce Neal et al. DIABETES CARE
- Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
- (2014) K. Kaku et al. DIABETES OBESITY & METABOLISM
- Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease
- (2014) Clement Lo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease
- (2014) Richard J. McManus et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin in Patients With Type 2 Diabetes and Kidney Disease
- (2014) Silvio E. Inzucchi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Sodium Consumption and Death from Cardiovascular Causes
- (2014) Dariush Mozaffarian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review
- (2014) Patrick M. Zueger et al. PHARMACOECONOMICS
- Effect of Information and Telephone-Guided Access to Community Support for People with Chronic Kidney Disease: Randomised Controlled Trial
- (2014) Tom Blakeman et al. PLoS One
- Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
- (2014) Lancet Diabetes & Endocrinology
- Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial
- (2014) Arjan J Kwakernaak et al. Lancet Diabetes & Endocrinology
- Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
- (2014) Lancet Diabetes & Endocrinology
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
- (2014) Anthony H Barnett et al. Lancet Diabetes & Endocrinology
- Direct and Indirect Effects of Obesity on the Kidney
- (2013) Radica Z. Alicic et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts
- (2013) David R Jesudason et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
- (2013) Wendy L. Bennett et al. ANNALS OF INTERNAL MEDICINE
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
- (2013) Despoina Vasilakou et al. ANNALS OF INTERNAL MEDICINE
- Effect of shared care on blood pressure in patients with chronic kidney disease: a cluster randomised controlled trial
- (2013) Nynke D Scherpbier-de Haan et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Measurement of Hba1C in patients with chronic renal failure
- (2013) Randie R. Little et al. CLINICA CHIMICA ACTA
- Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
- (2013) E. Jennifer Weil et al. DIABETES
- Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) Ian H. de Boer et al. DIABETES CARE
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
- (2013) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
- (2013) J. Konya et al. DIABETIC MEDICINE
- Effects of low-dose thiazide diuretics on fasting plasma glucose and serum potassium–a meta-analysis
- (2013) Bertrand N. Mukete et al. Journal of the American Society of Hypertension
- Association between Physical Performance and All-Cause Mortality in CKD
- (2013) B. Roshanravan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
- (2013) Donald E. Kohan et al. KIDNEY INTERNATIONAL
- Effects of weight loss on renal function in obese CKD patients: a systematic review
- (2013) Davide Bolignano et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors
- (2012) Harikrishna Makani et al. AMERICAN JOURNAL OF CARDIOLOGY
- Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis
- (2012) Aslak Steinsbekk et al. BMC HEALTH SERVICES RESEARCH
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists
- (2012) Marina Bullo et al. HYPERTENSION
- Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999–2006
- (2012) S D Navaneethan et al. INTERNATIONAL JOURNAL OF OBESITY
- A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: a feasibility randomized controlled trial
- (2012) Allison Williams et al. JOURNAL OF ADVANCED NURSING
- GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
- (2012) Massimo Brunetti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Diabetes quality improvement: beyond glucose control
- (2012) Martha M Funnell et al. LANCET
- Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
- (2012) Marcello Tonelli et al. LANCET
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exercise in Individuals With CKD
- (2011) Kirsten L. Johansen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dose Response Between Physical Activity and Risk of Coronary Heart Disease
- (2011) Jacob Sattelmair et al. CIRCULATION
- A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community: A Randomized Controlled Trial
- (2011) B. J. Barrett et al. Clinical Journal of the American Society of Nephrology
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements: The National Health and Nutrition Examination Survey, 1999-2006
- (2011) L. Reinstatler et al. DIABETES CARE
- Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
- (2011) R. Miccoli et al. DIABETES CARE
- The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes
- (2011) M. C. Thomas et al. DIABETES CARE
- Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study
- (2011) W. Crasto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
- (2011) S. Zoungas et al. DIABETOLOGIA
- Endogenous factors modified by hemodialysis may interfere with the accuracy of blood glucose-measuring device
- (2011) Tomonari Ogawa et al. Hemodialysis International
- Influence of Proteinuria on Glycated Albumin Values in Diabetic Patients with Chronic Kidney Disease
- (2011) Tomonari Okada et al. INTERNAL MEDICINE
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring
- (2011) FREDERIEK E VOS et al. NEPHROLOGY
- The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial
- (2011) S.-H. Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease
- (2011) G. C. Kosmadakis et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Physical Activity and Albuminuria
- (2010) E. S. Robinson et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4
- (2010) Harn-Shen Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Relationship between Assays of Glycemia in Diabetic Subjects with Advanced Chronic Kidney Disease
- (2010) Barry I. Freedman et al. AMERICAN JOURNAL OF NEPHROLOGY
- The devil is in the detail - a multifactorial intervention to reduce blood pressure in co-existing diabetes and chronic kidney disease: a single blind, randomized controlled trial
- (2010) Allison F Williams et al. BMC Family Practice
- The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney Disease
- (2010) J. M. Ng et al. DIABETES CARE
- Analysis of Hemodialysis-Associated Hypoglycemia in Patients with Type 2 Diabetes Using a Continuous Glucose Monitoring System
- (2010) Hye Seung Jung et al. Diabetes Technology & Therapeutics
- Inter-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Patients on Hemodialysis
- (2010) Marco Mirani et al. Diabetes Technology & Therapeutics
- AGREE II: Advancing guideline development, reporting and evaluation in health care
- (2010) Melissa C. Brouwers et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease
- (2010) Meg J. Jardine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
- (2010) Craig J Currie et al. LANCET
- Severe Hypoglycemia and Risks of Vascular Events and Death
- (2010) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- COMPARISON OF GLYCATED ALBUMIN AND HEMOGLOBIN A1c CONCENTRATIONS IN DIABETIC SUBJECTS ON PERITONEAL AND HEMODIALYSIS
- (2010) B. I. Freedman et al. PERITONEAL DIALYSIS INTERNATIONAL
- Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
- (2010) Juliana Levy et al. Diabetology & Metabolic Syndrome
- What can we learn from the recent blood glucose lowering megatrials?
- (2010) Juliana CN Chan Journal of Diabetes Investigation
- Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study
- (2009) David J Leehey et al. Cardiovascular Diabetology
- Physical Activity and Mortality in Chronic Kidney Disease (NHANES III)
- (2009) S. Beddhu et al. Clinical Journal of the American Society of Nephrology
- Weight Loss Interventions in Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2009) S. D. Navaneethan et al. Clinical Journal of the American Society of Nephrology
- Effects of Salt Supplementation on the Albuminuric Response to Telmisartan With or Without Hydrochlorothiazide Therapy in Hypertensive Patients With Type 2 Diabetes Are Modulated by Habitual Dietary Salt Intake
- (2009) E. I. Ekinci et al. DIABETES CARE
- Effects of Structured Versus Usual Care on Renal Endpoint in Type 2 Diabetes: The SURE Study: A randomized multicenter translational study
- (2009) J. C. Chan et al. DIABETES CARE
- Costs and Benefits Associated With Diabetes Education A Review of the Literature
- (2009) Suzanne A. Boren et al. DIABETES EDUCATOR
- Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
- (2009) D. Koya et al. DIABETOLOGIA
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system
- (2009) Jean-Pierre Riveline et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Self-Efficacy and Self-Management Behaviors in Patients With Chronic Kidney Disease
- (2008) Roberta Braun Curtin et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Physical Activity and Hemodynamic Reactivity in Chronic Kidney Disease
- (2008) R. Agarwal et al. Clinical Journal of the American Society of Nephrology
- Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
- (2008) P. Gaede et al. DIABETES CARE
- Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study
- (2008) L. A. Donnelly et al. DIABETES OBESITY & METABOLISM
- Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
- (2008) T.P. Peacock et al. KIDNEY INTERNATIONAL
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial
- (2008) Nina E. S. S. Perrin et al. PEDIATRIC NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now